Crohn's disease: Genetic aspects


Cite item

Full Text

Abstract

The paper deals with the topical problem of modern gastroenterology and coloproctology - the influence of genetic factors on the development and course of Crohn's disease (CD). It presents the data of foreign authors and the results of Russia's first study evaluating the effect of the major polymorphic variants of the NOD2/CARD15 gene predisposing to CD on the risk, course, and other features of CD.

References

  1. Crohn B. B., Ginzburg L., Oppenheimer G. G. Regional ileitis, a pathological and clinical entity. J. A. M. A. 1932; 99: 1323- 1328.
  2. Loftus E. V. Crohn's disease in Olmsted Country, Minnesota 1940-1993: incidence, prevalence, survival. Gastroenterology 1998; 114 (6): 1160-1168.
  3. Loftus E. V., Blanchard J. F. Jr., Sormenberg A. Epidemiology. Clinical Science. Adult Challenges in Inflammatory Bowel Diseases. The Crohn's and Colitis Foundation of America 2008; May 5th: http:/www.ccfa.org/ ccfaprof/res-resources/articles/Epidemiology.pdf.
  4. Binder V. Genetic epidemiology of inflammatory bowel disease. Dig. Dis. 1998; 16: 351-355.
  5. Ogunbi S. O., Ransom J. A., Sullivan K. et al. Inflammatory bowel disease in African-American children living in Georgia. J. Pediatr. 1998; 133: 103-107.
  6. Sugimura K., Taylor K. D., Lin Y. C. et al. A novel NOD2/ CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am. J. Hum. Genet. 2003; 72: 509-518.
  7. Менахем И., Вайцман Ц., Лукер X. Сравнение клинических характеристик болезни Крона у детей и подростков и у взрослых. Международ. мед. журн. 1999; 1-2: 97-99.
  8. Никулина И. В., Златкина А. Р., Белоусова Е. А. и др. Оценка клинико-эпидемиологических показателей воспалительных заболеваний кишечника в Московской области. Рос. журн. гастроэнтерол., гепатол., колопроктол. 1997; 2: 67-71.
  9. Daly Mark J. et al. Genome-wide association defines more than thirty distinct susceptibility loci for Crohn's disease. Nat. Genet. 2008; 40: 955-962. doi: 10.1038/ng.175.
  10. Peeters M., Vermeire S., Rutgeerts P. Genetics and IBD: What to tell our patients today? Falk Symp. 1998; 106: 11.
  11. Binder V., Orholm M. Familialoccurence and inheritance studies in inflammatory bowel disease. Netherl. J. Med. 1996; 48 (2): 53-56.
  12. Orholm M., Binder V., Sorensen T. I. A., Kyvik K. Inflammatory bowel disease in a Danish twin register. Gut 1996; 39 (suppl. 3): A187.
  13. Breslin N. P., Todd A., Kilgallen C., O'Morain C. Monozygotic twins with Crohn's disease and ulcerative colitis: a unique case report. Gut 1997; 41: 557-560.
  14. Хаитов P. M., Алексеев Л. П. Генетика иммунного ответа. Бюл. Сиб. отд-ния. РАМН 1998; 2: 27-33.
  15. Mathew С. G., Lewis С. М. Genetics of inflammatory bowel disease: progress and prospects. Hum. Mol. Genet. 2004; 13: R161-R168.
  16. Ogura Y., Bonen D. K., Inohara N. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
  17. Ahmad Т., Satsangi J., McGovern D. et al. The genetics of inflammatory bowel diseases. Aliment. Pharmacol. Ther. 2001; 15 (6): 731-748.
  18. Satsangy J., Jewel D. P., Bell J. I. The genetics of inflammatory bowel diseases. (Leading article). Gut 1997; 40: 572-574.
  19. Халиф И. Л., Лоранская И. Д. Воспалительные заболевания кишечника (неспецифический язвенный колит и болезнь Крона). Клиника, диагностика и лечение. М.: Миклош; 2004.
  20. Белоусова Е. К. Язвенный колит и болезнь Крона. Тверь: ООО "Изд-во "Триада"; 2002.
  21. Mirza M. M., Fisher S. A., King K. et al. Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. Am. J. Hum. Genet. 2003; 72: 1018-1022.
  22. Negoro K., McGovern D. P., Kinouchi Y. et al. Analysis of the IBD5 locus and potential gene-gene interactions in Crohn's disease. Gut 2003; 52: 541-546.
  23. Armuzzi A., Ahmad Т., Ling K. L. et al. Genotype- phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut 2003; 52: 1133-1139.
  24. Stoll M., Corneliussen В., Costello C. M. et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat. Genet. 2004; 36: 476-480.
  25. Matsuzawa J., Sugimura K., Matsuda Y. et al. Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in a Japanese population. Gut 2003; 52: 75-78.
  26. Duerr R. H., Taylor K. D., Brant S. R. et al. A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene. Published Online October 26 2006; Science doi: 10.1126/science.1135245.
  27. Hampe J., Franke A., Rosenstiel Ph. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 2006; 39: 207-211.
  28. Hugot J. P., Chamaillard M., Zouali H. et al. Association of NOD2 leucinerich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
  29. Hampe J., Cuthbert A., Croucher P. J. et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925- 1928.
  30. Inohara N., Ogura Y., Fontalba A. et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem 2003; 278: 5509- 5512.
  31. Girardin S. E., Boneca I. G., Viala J. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol Chem. 2003; 278: 8869-8872.
  32. Lala S., Ogura Y., Osborne C. et al. Crohn's disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 2003; 125: 47-57.
  33. Lesage S., Zouali H., Cezard J.-P. et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet. 2002; 70: 845-857.
  34. Bonen D. K., Ogura Y., Nicolae D. L. et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003; 124: 140-146.
  35. Colombel J. F. The CARD15 (also known as NOD2) gene in Crohn's disease: are there implications for current clinical practice? Clin. Gastroenterol. Hepatol. 2003; 1: 5-9.
  36. Buning C., Molnar Т., Nagy F. et al. NOD2/CARD15 gene polymorphism in patients with inflammatory bowel disease: Is Hungary different? Wld J. Gastroenterol. 2005; 11 (3): 407- 411.
  37. Bonen D. K., Cho J. H. The genetics of inflammatory bowel disease. Gastroenterology 2003; 124: 521-536.
  38. Inoue N., Tamura K., Kinouchi Y. et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002; 123: 86-91.
  39. Croucher P. J., Mascheretti S., Hampe J. et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur. J. Hum. Genet. 2003; 11: 6-16.
  40. Fiocchi С. Многофакторный патогенез ВЗК. Лекция мастер-класса на Фальк-симпозиуме № 154, Москва, 9-10 июня 2006 г.
  41. Kobayashi K. S. et al. Nod-2 dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307: 731-734.
  42. Strober W., Fuss I., Mannon P. The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 2007; 117 (3): 514- 521.
  43. Fellermann K., Wehkamp J., Herrlinger K. R. et al. Crohn's disease: a defensin deficiency syndrome? Eur. J. Gastroenterol. Hepatol. 2003; 15: 627-634.
  44. Chamaillard M., Philpott D., Girardin S. E. et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl. Acad. Sci. USA 2003; 100: 3455-3460.
  45. Pauleau A. L., Murray P. J. Role of Nod2 in the response of macrophages to Toll-like receptor agonists. Mol. Cell. Biol. 2003; 23: 7531-7539.
  46. Hampe J., Grebe J., Nikolaus S. et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002; 359: 1661-1665.
  47. Brant S. R., Picco M. F., Achkar J. P. et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm. Bowel Dis. 2003; 9: 281-289.
  48. Gazouli M., Zacharatos P., Mantzaris G. J. et al. Association of NOD2/CARD15 variants with Crohn's disease in a Greek population. Eur. J. Gastroenterol. Hepatol. 2004; 16: 1177- 1182.
  49. Kugathasan S., Loizides A., Babusukumar U. et al. Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and White children with Crohn's disease. Inflamm. Bowel Dis. 2005; 11: 631-638.
  50. Louis E., Michel V., Hugot J. P. et al. Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 2003; 52: 552-557.
  51. Radford-Smith G., Pandeya N. Associations between NOD2/ CARD15 genotype and phenotype in Crohn's disease-are we there yet? Wld J. Gastroenterol. 2006; 12 (44): 7097-7103.
  52. Buhner S., Buning C., Genschel J. et al. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 c.3020insC mutation? Gut 2006; 55: 342- 347.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies